CIK 0001133869 · Non-accelerated filer<br>Smaller reporting company
CAPRICOR THERAPEUTICS, INC.
Sign in to watch- Ticker
- CAPR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (310) 358-3200
- Business address
- 10865 ROAD TO THE CURE, SUITE 150, SAN DIEGO, CA, 92121
- Former names
- Nile Therapeutics, Inc., SMI PRODUCTS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 97 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-02 | DUNBAR GEORGE W JR Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-06-02 | Litvack Frank Director | Grant or award · Stock Option (right to buy) | +39,375 | 39,375 | ||
| 2016-06-02 | Musket David B Director | Grant or award · Stock Option (right to buy) | +46,458 | 46,458 | ||
| 2016-06-02 | COLLIER EARL M JR Director | Grant or award · Stock Option (right to buy) | +24,375 | 24,375 | ||
| 2016-06-02 | Bergmann Anthony Vice President of Finance | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2016-03-16 | CEDARS SINAI MEDICAL CENTER 10% owner | Purchase | +416,666 | $2.40 | $1000K | 2,592,298 |
| 2016-03-16 | CEDARS SINAI MEDICAL CENTER 10% owner | Purchase · Warrants (Right to Buy) | +208,333 | $0.00 | $208 | 208,333 |
| 2016-03-16 | GERSHELL LELAND CHIEF FINANCIAL OFFICER | Purchase | +2,100 | $2.40 | $5K | 2,100 |
| 2016-03-16 | GERSHELL LELAND CHIEF FINANCIAL OFFICER | Purchase · Warrants (Right to Buy) | +1,050 | $0.13 | $131 | 1,050 |
| 2016-03-16 | Krasney Karen EVP, General Counsel | Purchase | +4,060 | $2.40 | $10K | 11,156 |
| 2016-03-16 | Krasney Karen EVP, General Counsel | Purchase · Warrants (Right to Buy) | +2,030 | $0.13 | $254 | 2,030 |
| 2016-03-16 | Marban Linda Chief Executive Officer | Purchase | +10,152 | $2.40 | $24K | 273,709 |
| 2016-03-16 | Marban Linda Chief Executive Officer | Purchase · Warrants (Right to Buy) | +5,076 | $0.13 | $635 | 5,076 |
| 2016-03-16 | Bergmann Anthony Vice President of Finance | Purchase | +2,030 | $2.40 | $5K | 2,030 |
| 2016-03-16 | Bergmann Anthony Vice President of Finance | Purchase · Warrants (Right to Buy) | +1,015 | $0.13 | $127 | 1,015 |
| 2016-03-16 | Manzo Louis Director | Purchase | +100,000 | $2.40 | $240K | 128,384 |
| 2016-03-16 | Manzo Louis Director | Purchase · Warrants (Right to Buy) | +50,000 | $0.13 | $6K | 50,000 |
| 2016-03-16 | GRASMICK LOUIS J Director | Purchase | +71,065 | $2.40 | $171K | 77,015 |
| 2016-03-16 | GRASMICK LOUIS J Director | Purchase | +20,304 | $2.40 | $49K | 1,059,740 |
| 2016-03-16 | GRASMICK LOUIS J Director | Purchase · Warrants (Right to Buy) | +35,532 | $0.13 | $4K | 35,532 |
Page 22 of 24 · 468 trades